Ferric citrate reduces fibroblast growth factor 23 levels and improves renal and cardiac function in a mouse model of chronic kidney disease

Iron deficiency, anemia, hyperphosphatemia, and increased fibroblast growth factor 23 (FGF23) are common and interrelated complications of chronic kidney disease (CKD) that are linked to CKD progression, cardiovascular disease and death. Ferric citrate is an oral phosphate binder that decreases diet...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Kidney Int
Hlavní autoři: Francis, Connor, Courbon, Guillaume, Gerber, Claire, Neuburg, Samantha, Wang, Xueyan, Dussold, Corey, Capella, Maralee, Qi, Lixin, Isakova, Tamara, Mehta, Rupal, Martin, Aline, Wolf, Myles, David, Valentin
Médium: Artigo
Jazyk:Inglês
Vydáno: 2019
Témata:
Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC6875640/
https://ncbi.nlm.nih.gov/pubmed/31668632
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.kint.2019.07.026
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky